Back to top
more

AMN Healthcare Services (AMN)

(Delayed Data from NYSE)

$52.03 USD

52.03
731,989

+0.17 (0.33%)

Updated Aug 16, 2024 04:00 PM ET

After-Market: $52.04 +0.01 (0.02%) 5:28 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 41% (149 out of 251)

Industry: Medical Services

Better trading starts here.

Zacks News

AMN Healthcare Services (AMN) Q4 Earnings and Revenues Surpass Estimates

AMN Healthcare (AMN) delivered earnings and revenue surprises of 4.76% and 1.89%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Debanjana Dey headshot

Medical Products Stocks' Earnings Due on Feb 15: WST, ITGR & More

Medical Products companies' quarterly results are likely to reflect strength in customer demand. Let's see how ITGR, WST, AMN and PACB are placed ahead of their earnings releases.

What Analyst Projections for Key Metrics Reveal About AMN Healthcare (AMN) Q4 Earnings

Get a deeper insight into the potential performance of AMN Healthcare (AMN) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Analysts Estimate AMN Healthcare Services (AMN) to Report a Decline in Earnings: What to Look Out for

AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

McKesson (MCK) to Report Q3 Earnings: What's in the Cards?

McKesson's (MCK) third-quarter fiscal 2024 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment.

Baxter (BAX) to Report Q4 Earnings: What's in the Cards?

Baxter's (BAX) fourth-quarter results are likely to reflect growth in elective surgical procedures, offset by currency movement. Hillrom's products might have boosted sales.

DexCom (DXCM) to Report Q4 Earnings: Is a Beat in Store?

DexCom's (DXCM) fourth-quarter 2023 results are likely to reflect rising volumes across all channels.

GE HealthCare (GEHC) to Report Q4 Earnings: What's in Store?

GE HealthCare (GEHC) is expected to report strong organic revenue growth, banking on balanced segmental performance, driven by consistent NPIs and growing customer demand.

What's in Store for Cardinal Health (CAH) in Q2 Earnings?

Cardinal Health's (CAH) second-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical segment.

Cencora (COR) to Report Q1 Earnings: What's in the Cards?

Cencora's (COR) first-quarter fiscal 2024 results are likely to reflect solid performance at the U.S. Healthcare Solutions segment.

Stryker (SYK) to Report Q4 Earnings: What's in the Cards?

Stryker's (SYK) fourth-quarter 2023 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued hurting margins.

Revvity (RVTY) to Report Q4 Earnings: What's in the Cards?

Revvity's (RVTY) fourth-quarter results are likely to reflect weak performance at the Diagnostics segment, partially offset by strong demand for its Life Sciences and Diagnostics franchises.

Will AMN Healthcare (AMN) Beat Estimates Again in Its Next Earnings Report?

AMN Healthcare (AMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Here's How Much You'd Have If You Invested $1000 in AMN Healthcare Services a Decade Ago

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Charles River (CRL) Up 19.7% Since Last Earnings Report: Can It Continue?

Charles River (CRL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

AMN Healthcare's (AMN) New Tie-Up to Boost Patient Outcome

AMN Healthcare's (AMN) collaboration is likely to bolster its portfolio of products and simplify the language procurement process for customers.

3 Reasons to Retain AMN Healthcare (AMN) Stock in Your Portfolio

Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.

Implied Volatility Surging for AMN Healthcare (AMN) Stock Options

Investors need to pay close attention to AMN Healthcare (AMN) stock based on the movements in the options market lately.

AMN Healthcare (AMN) Q3 Earnings and Revenues Beat Estimates

AMN Healthcare's (AMN) dismal results in all its segments led to a soft overall third-quarter performance.

AMN Healthcare (AMN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for AMN Healthcare (AMN) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Implied Volatility Surging for AMN Healthcare (AMN) Stock Options

Investors need to pay close attention to AMN Healthcare (AMN) stock based on the movements in the options market lately.

New Strong Sell Stocks for September 6th

AMN, ARR and CFBK have been added to the Zacks Rank #5 (Strong Sell) List on September 6, 2023.

New Strong Sell Stocks for August 30th

AFCG, AMN and DNOW have been added to the Zacks Rank #5 (Strong Sell) List on August 30, 2023.

AMN Healthcare (AMN) Q2 Earnings and Revenues Beat Estimates

AMN Healthcare's (AMN) dismal results in all its segments led to a soft overall Q2 performance.